JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

JNJ

225.07

-1.1%↓

ABT

92.85

+1.8%↑

MDT

82.92

-0.55%↓

A

115.57

+0.14%↑

VEEV

160.16

-0.42%↓

Search

McKesson Corp

Fermé

SecteurSoins de santé

826.76 0.16

Résumé

Variation du prix de l'action

24h

Actuel

Min

822.13

Max

834.7

Chiffres clés

By Trading Economics

Revenu

40M

1.3B

Ventes

3B

106B

P/E

Moyenne du Secteur

24.813

60.328

Rendement du dividende

0.35

Marge bénéficiaire

1.177

Employés

43,000

EBITDA

374M

1.8B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+18.33% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

0.35%

2.24%

Prochains Résultats

7 mai 2026

Date du Prochain Dividende

1 juil. 2026

Date du Prochain Détachement de Dividende

1 juin 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

736M

106B

Ouverture précédente

826.6

Clôture précédente

826.76

Sentiment de l'Actualité

By Acuity

34%

66%

76 / 348 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

McKesson Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

27 avr. 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Consumers Pay Less But Full Impact of Mideast War to Be Seen

27 avr. 2026, 23:08 UTC

Résultats
Principaux Mouvements du Marché

LendingClub Shares Gain on 1Q Profit, Revenue Beat

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net Profit Beat FactSet-Compiled Consensus

27 avr. 2026, 23:58 UTC

Résultats

Samsung SDI 1Q Net KRW56.10B Vs. Loss KRW216.00B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Oper Loss KRW155.60B Vs. Loss KRW434.10B >006400.SE

27 avr. 2026, 23:56 UTC

Résultats

Samsung SDI 1Q Rev KRW3.576T Vs. KRW3.177T >006400.SE

27 avr. 2026, 23:48 UTC

Market Talk

Nikkei May Remain Rangebound Amid Uncertainty Over Iran Conflict -- Market Talk

27 avr. 2026, 23:42 UTC

Market Talk

Australian Consumer Confidence Making a Slow Come Back -- Market Talk

27 avr. 2026, 23:34 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher as Investors Assess Iran's Proposal to U.S. -- Market Talk

27 avr. 2026, 23:30 UTC

Market Talk

Australia's NDIS Could Lose 'Social Licence' If Not Reined In -- Market Talk

27 avr. 2026, 23:08 UTC

Market Talk

Polymetals's Revenue Outlook 'Extraordinary' for a Small-Cap Stock -- Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 avr. 2026, 23:02 UTC

Market Talk

Warsh Will Probably Lean a Bit More Dovish Than Powell -- Market Talk

27 avr. 2026, 22:42 UTC

Market Talk

BOJ Expected to Keep Rates On Hold; Guidance to Skew Hawkish -- Market Talk

27 avr. 2026, 22:10 UTC

Résultats

Haier Smart Home: Results Also Weighed by Weak Demand in China-U.S. Markets >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home: Increase in Tariff Costs, Extreme Weather Conditions Hurt Results >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Net CNY4.65B Vs. Net CNY5.49B >600690.SH

27 avr. 2026, 22:09 UTC

Résultats

Haier Smart Home 1Q Rev CNY73.69B Vs. CNY79.12B >600690.SH

27 avr. 2026, 21:56 UTC

Résultats

Tsingtao Brewery: Cost Controls Among Factors Supporting Results >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Net CNY1.80B Vs. Net CNY1.71B >0168.HK

27 avr. 2026, 21:55 UTC

Résultats

Tsingtao Brewery 1Q Rev CNY10.29B Vs. CNY10.45B >0168.HK

27 avr. 2026, 21:44 UTC

Résultats

Tianqi Lithium: Higher Demand for Products From EV Sector Also Boosted Financial Performance >002466.SZ

27 avr. 2026, 21:43 UTC

Résultats

Tianqi Lithium: Increase in Average Selling Prices of Major Lithium Products Supported Results >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Rev CNY5.13B Vs. CNY2.58B >002466.SZ

27 avr. 2026, 21:41 UTC

Résultats

Tianqi Lithium 1Q Net CNY1.88B Vs. Net CNY104.27M >002466.SZ

27 avr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Financial Services Roundup: Market Talk

27 avr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 avr. 2026, 20:39 UTC

Résultats

Nucor: Operating Segments Earnings Growth Driven by Trade Policies That Continue to Reduce Flood of Unfairly Traded Imports Into U.S. >NUE

Comparaison

Variation de prix

McKesson Corp prévision

Objectif de Prix

By TipRanks

18.33% hausse

Prévisions sur 12 Mois

Moyen 979.89 USD  18.33%

Haut 1,107 USD

Bas 885 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

11 ratings

9

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

681.92 / 707.28Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

No Evidence

Long Terme

No Evidence

Sentiment

By Acuity

76 / 348Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat